Skip to content

STEMLINE THERAPEUTICS INC

CIK 0001264587

← back to feed
Revenue (TTM)
$14.72M
−44.3% YoY Q1 May 2020
Net Income (TTM)
−$80.43M
−18.7% YoY Q1 May 2020
EPS Diluted (TTM)
—
Q1 May 2020
Gross Margin
83.8%
Q1 May 2020
Operating Margin
-562.2%
Q1 May 2020
Net Margin
-546.4%
Q1 May 2020
Free Cash Flow (TTM)
—
Q1 May 2020
Cash
$29.23M
Q1 May 2020
Total Debt
—
Q1 May 2020
Shares Outstanding
52.51M sh
Q1 May 2020

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings